1 |
Chen, E. I. and Yates, J. R., 3rd (2007) Cancer proteomics by quantitative shotgun proteomics. Mol. Oncol. 1, 144-159.
DOI
ScienceOn
|
2 |
Ong, S. E., Foster, L. J. and Mann, M. (2003) Mass spectrometric-based approaches in quantitative proteomics. Methods 29, 124-130.
DOI
ScienceOn
|
3 |
Shi, T., Su, D., Liu, T., Tang, K., Camp, D. G., 2nd, Qian, W. J. and Smith, R. D. (2012) Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 12, 1074-1092.
DOI
ScienceOn
|
4 |
Honda, K., Ono, M., Shitashige, M., Masuda, M., Kamita, M., Miura, N. and Yamada, T. (2013) Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. J. Clin. Oncol. 43, 103-109.
|
5 |
Cumova, J., Potacova, A., Zdrahal, Z. and Hajek, R. (2011) Proteomic analysis in multiple myeloma research. Mol. Biotechnol. 47, 83-93.
DOI
|
6 |
Chen, S., Zhao, H., Deng, J., Liao, P., Xu, Z. and Cheng, Y. (2013) Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target. J. Cell Biochem. 114, 2795-2808.
DOI
ScienceOn
|
7 |
Blagoev, B., Kratchmarova, I., Ong, S. E., Nielsen, M., Foster, L. J. and Mann, M. (2003) A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 21, 315-318.
DOI
ScienceOn
|
8 |
Oberg, A. L. and Mahoney, D. W. (2012) Statistical methods for quantitative mass spectrometry proteomic experiments with labeling. BMC Bioinformatics 13(Suppl 16), S7.
|
9 |
Ducy, P., Schinke, T. and Karsenty, G. (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289, 1501-1504.
DOI
ScienceOn
|
10 |
Katagiri, T. and Takahashi, N. (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral. Dis. 8, 147-159.
DOI
ScienceOn
|
11 |
Kim, J. M., Kim, J., Kim, Y. H., Kim, K. T., Ryu, S. H., Lee, T. G. and Suh, P. G. Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis. J. Cell Physiol. 228, 216-224.
|
12 |
Boyle, W. J., Simonet, W. S. and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342.
DOI
ScienceOn
|
13 |
Caetano-Lopes, J., Canhao, H. and Fonseca, J. E. (2007) Osteoblasts and bone formation. Acta. Reumatol. Port. 32, 103-110.
|
14 |
Fakhry, M., Hamade, E., Badran, B., Buchet, R. and Magne, D. (2013) Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World. J. Stem. Cells. 5, 136-148.
DOI
ScienceOn
|
15 |
Friedenstein, A. J., Ivanov-Smolenski, A. A., Chajlakjan, R. K., Gorskaya, U. F., Kuralesova, A. I., Latzinik, N. W. and Gerasimow, U. W. (1978) Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. Exp. Hematol. 6, 440-444.
|
16 |
Salasznyk, R. M., Westcott, A. M., Klees, R. F., Ward, D. F., Xiang, Z., Vandenberg, S., Bennett, K. and Plopper, G. E. (2005) Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem. Cells Dev. 14, 354-366.
DOI
ScienceOn
|
17 |
Caplan, A. I. (1991) Mesenchymal stem cells. J. Orthop. Res. 9, 641-650.
DOI
|
18 |
Moussavou, G., Kwak, D. H., Lim, M. U., Kim, J. S., Kim, S. U., Chang, K. T. and Choo, Y. K. (2013) Role of gangliosides in the differentiation of human mesenchymal-derived stem cells into osteoblasts and neuronal cells. BMB Rep. 46, 527-532.
DOI
ScienceOn
|
19 |
Ding, J., Ghali, O., Lencel, P., Broux, O., Chauveau, C., Devedjian, J. C., Hardouin, P. and Magne, D. (2009) TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci. 84, 499-504.
DOI
ScienceOn
|
20 |
Kristensen, L. P., Chen, L., Nielsen, M. O., Qanie, D. W., Kratchmarova, I., Kassem, M. and Andersen, J. S. Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells. Mol. Cell Proteomics 11, 989-1007.
|
21 |
Lee, J. H., Kim, B. G., Ahn, J. M., Park, H. J., Park, S. K., Yoo, J. S., Yates, J. R., 3rd and Cho, J. Y. (2010) Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells. Bone 46, 1522-1532.
DOI
ScienceOn
|
22 |
Tamaki, Y., Nakahara, T., Ishikawa, H. and Sato, S. (2013) In vitro analysis of mesenchymal stem cells derived from human teeth and bone marrow. Odontology 101, 121-132.
DOI
ScienceOn
|
23 |
Canalis, E., Economides, A. N. and Gazzerro, E. (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev. 24, 218-235.
DOI
ScienceOn
|
24 |
Patil, R., Kumar, B. M., Lee, W. J., Jeon, R. H., Jang, S. J., Lee, Y. M., Park, B. W., Byun, J. H., Ahn, C. S., Kim, J. W. and Rho, G. J. (2014) Multilineage potential and proteomic profiling of human dental stem cells derived from a single donor. Exp. Cell Res. 320, 92-107.
DOI
ScienceOn
|
25 |
Xu, D. J., Zhao, Y. Z., Wang, J., He, J. W., Weng, Y. G. and Luo, J. Y. (2012) Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Rep. 45, 247-252.
DOI
ScienceOn
|
26 |
Chen, D., Zhao, M. and Mundy, G. R. (2004) Bone morphogenetic proteins. Growth Factors 22, 233-241.
DOI
ScienceOn
|
27 |
Li, X. and Cao, X. (2006) BMP signaling and skeletogenesis. Ann. N. Y. Acad. Sci. 1068, 26-40.
DOI
ScienceOn
|
28 |
Massague, J. (1998) TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
DOI
ScienceOn
|
29 |
Guicheux, J., Lemonnier, J., Ghayor, C., Suzuki, A., Palmer, G. and Caverzasio, J. (2003) Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone. Miner. Res. 18, 2060-2068.
DOI
ScienceOn
|
30 |
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
DOI
ScienceOn
|
31 |
Komori, T. (2011) Signaling networks in RUNX2-dependent bone development. J. Cell Biochem. 112, 750-755.
DOI
ScienceOn
|
32 |
Kim, B. G., Lee, J. H., Yasuda, J., Ryoo, H. M. and Cho, J. Y. Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-beta signaling. J. Bone. Miner. Res. 26, 1411-1424.
|
33 |
Cadigan, K. M. and Liu, Y. I. (2006) Wnt signaling: complexity at the surface. J. Cell Sci. 119, 395-402.
DOI
ScienceOn
|
34 |
Kim, B. G., Lee, J. H., Ahn, J. M., Park, S. K., Cho, J. H., Hwang, D., Yoo, J. S., Yates, J. R., 3rd, Ryoo, H. M. and Cho, J. Y. (2009) 'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast. J. Proteome. Res. 8, 4441-4454.
DOI
ScienceOn
|
35 |
Fotia, A. B., Ekberg, J., Adams, D. J., Cook, D. I., Poronnik, P. and Kumar, S. (2004) Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2. J. Biol. Chem. 279, 28930-28935.
DOI
ScienceOn
|
36 |
Pinzone, J. J., Hall, B. M., Thudi, N. K., Vonau, M., Qiang, Y. W., Rosol, T. J. and Shaughnessy, J. D., Jr. (2009) The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113, 517-525.
DOI
ScienceOn
|
37 |
Day, T. F., Guo, X., Garrett-Beal, L. and Yang, Y. (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750.
DOI
ScienceOn
|
38 |
Silverio, K. G., Davidson, K. C., James, R. G., Adams, A. M., Foster, B. L., Nociti, F. H., Jr., Somerman, M. J. and Moon, R. T. (2012) Wnt/beta-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells. J. Periodontal. Res. 47, 309-319.
DOI
ScienceOn
|
39 |
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
DOI
|
40 |
Zhang, R., Oyajobi, B. O., Harris, S. E., Chen, D., Tsao, C., Deng, H. W. and Zhao, M. (2013) Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52, 145-156.
DOI
ScienceOn
|
41 |
Krane, S. M. (2005) Identifying genes that regulate bone remodeling as potential therapeutic targets. J. Exp. Med. 201, 841-843.
DOI
ScienceOn
|
42 |
Takahashi, N., Udagawa, N. and Suda, T. (1999) A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256, 449-455.
DOI
ScienceOn
|
43 |
Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
DOI
ScienceOn
|
44 |
Gori, F., Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Khosla, S. and Riggs, B. L. (2000) The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141, 4768-4776.
DOI
|
45 |
Kim, H. H., Shin, H. S., Kwak, H. J., Ahn, K. Y., Kim, J. H., Lee, H. J., Lee, M. S., Lee, Z. H. and Koh, G. Y. (2003) RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. FASEB J. 17, 2163-2165.
DOI
|
46 |
Lamghari, M., Tavares, L., Camboa, N. and Barbosa, M. A. (2006) Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts. J. Cell. Biochem. 98, 1123-1129.
DOI
ScienceOn
|
47 |
Fantner, G. E., Birkedal, H., Kindt, J. H., Hassenkam, T., Weaver, J. C., Cutroni, J. A., Bosma, B. L., Bawazer, L., Finch, M. M., Cidade, G. A., Morse, D. E., Stucky, G. D. and Hansma, P. K. (2004) Influence of the degradation of the organic matrix on the microscopic fracture behavior of trabecular bone. Bone 35, 1013-1022.
DOI
ScienceOn
|
48 |
Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J. and Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176.
DOI
ScienceOn
|
49 |
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N. and Suda, T. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U. S. A. 95, 3597-3602.
DOI
ScienceOn
|
50 |
Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T. and Wakabayashi, K. (2002) PDGF BB purified from osteoclasts acts as osteoblastogenesis inhibitory factor (OBIF). J. Biomol. Tech. 13, 62-71.
|
51 |
Kubota, K., Sakikawa, C., Katsumata, M., Nakamura, T. and Wakabayashi, K. (2002) Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor. J. Bone. Miner. Res. 17, 257-265.
DOI
ScienceOn
|
52 |
Wu, L. N., Genge, B. R. and Wuthier, R. E. (1991) Association between proteoglycans and matrix vesicles in the extracellular matrix of growth plate cartilage. J. Biol. Chem. 266, 1187-1194.
|
53 |
Kubota, K., Wakabayashi, K. and Matsuoka, T. (2003) Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two-dimensional electrophoresis and isotope-coded affinity tags analysis with two-dimensional chromatography. Proteomics 3, 616-626.
DOI
ScienceOn
|
54 |
Baum, J. and Brodsky, B. (1999) Folding of peptide models of collagen and misfolding in disease. Curr. Opin. Struct. Biol. 9, 122-128.
DOI
ScienceOn
|
55 |
Balcerzak, M., Malinowska, A., Thouverey, C., Sekrecka, A., Dadlez, M., Buchet, R. and Pikula, S. (2008) Proteome analysis of matrix vesicles isolated from femurs of chicken embryo. Proteomics 8, 192-205.
DOI
ScienceOn
|
56 |
Kirsch, T., Harrison, G., Golub, E. E. and Nah, H. D. (2000) The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J. Biol. Chem. 275, 35577-35583.
DOI
ScienceOn
|
57 |
Kassem, M., Abdallah, B. M. and Saeed, H. (2008) Osteoblastic cells: differentiation and trans-differentiation. Arch. Biochem. Biophys. 473, 183-187.
DOI
ScienceOn
|
58 |
Choi, Y. A., Lim, J., Kim, K. M., Acharya, B., Cho, J. Y., Bae, Y. C., Shin, H. I., Kim, S. Y. and Park, E. K. (2010) Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J. Proteome. Res. 9, 2946-2956.
DOI
ScienceOn
|
59 |
Bjornaes, I. and Rofstad, E. K. (2001) Transvascular and interstitial transport of a 19 kDa linear molecule in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 14, 608-616.
DOI
ScienceOn
|
60 |
Kim, J. M., Kim, J., Kim, Y. H., Kim, K. T., Ryu, S. H., Lee, T. G. and Suh, P. G. (2013) Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis. J. Cell Physiol. 228, 216-224.
DOI
ScienceOn
|
61 |
Martinek, N., Shahab, J., Sodek, J. and Ringuette, M. (2007) Is SPARC an evolutionarily conserved collagen chaperone? J. Dent. Res. 86, 296-305.
DOI
ScienceOn
|
62 |
Alves, R. D., Eijken, M., Bezstarosti, K., Demmers, J. A. and van Leeuwen, J. P. (2013) Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production. Mol. Cell Proteomics 12, 2890-2900.
DOI
ScienceOn
|
63 |
Li, J., Zhang, F. and Chen, J. Y. (2011) An integrated proteomics analysis of bone tissues in response to mechanical stimulation. BMC. Syst. Biol. 5(Suppl 3), S7.
|
64 |
Kim, H. K., Woo, E. R., Lee, H. W., Park, H. R., Kim, H. N., Jung, Y. K., Choi, J. Y., Chae, S. W., Kim, H. R. and Chae, H. J. (2008) The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone. Immunopharmacol. Immunotoxicol. 30, 347-364.
DOI
ScienceOn
|
65 |
Yokozawa, T., Chung, H. Y., Dong, E. and Oura, H. (1995) Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. Exp. Toxicol. Pathol. 47, 341-344.
DOI
ScienceOn
|
66 |
Park, B. W., Kang, E. J., Byun, J. H., Son, M. G., Kim, H. J., Hah, Y. S., Kim, T. H., Mohana Kumar, B., Ock, S. A. and Rho, G. J. (2012) In vitro and in vivo osteogenesis of human mesenchymal stem cells derived from skin, bone marrow and dental follicle tissues. Differentiation 83, 249-259.
DOI
ScienceOn
|
67 |
Thouverey, C., Malinowska, A., Balcerzak, M., Strzelecka-Kiliszek, A., Buchet, R., Dadlez, M. and Pikula, S. (2011) Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells. J. Proteomics 74, 1123-1134.
DOI
ScienceOn
|
68 |
Liu, N. Q., Dekker, L. J., Stingl, C., Guzel, C., De Marchi, T., Martens, J. W., Foekens, J. A., Luider, T. M. and Umar, A. (2013) Quantitative Proteomic Analysis of Microdissected Breast Cancer Tissues: Comparison of Label-Free and SILAC-based Quantification with Shotgun, Directed, and Targeted MS Approaches. J. Proteome. Res. 12, 4627-4641.
DOI
ScienceOn
|
69 |
Mertins, P., Udeshi, N. D., Clauser, K. R., Mani, D. R., Patel, J., Ong, S. E., Jaffe, J. D. and Carr, S. A. (2012) iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol. Cell Proteomics 11, M111 014423.
|
70 |
Lo, T., Tsai, C. F., Shih, Y. R., Wang, Y. T., Lu, S. C., Sung, T. Y., Hsu, W. L., Chen, Y. J. and Lee, O. K. Phosphoproteomic analysis of human mesenchymal stromal cells during osteogenic differentiation. J. Proteome. Res. 11, 586-598.
|
71 |
Rainger, J., van Beusekom, E., Ramsay, J. K., McKie, L., Al-Gazali, L., Pallotta, R., Saponari, A., Branney, P., Fisher, M., Morrison, H., Bicknell, L., Gautier, P., Perry, P., Sokhi, K., Sexton, D., Bardakjian, T. M., Schneider, A. S., Elcioglu, N., Ozkinay, F., Koenig, R., Megarbane, A., Semerci, C. N., Khan, A., Zafar, S., Hennekam, R., Sousa, S. B., Ramos, L., Garavelli, L., Furga, A. S., Wischmeijer, A., Jackson, I. J., Gillessen-Kaesbach, G., Brunner, H. G., Wieczorek, D., van Bokhoven, H. and Fitzpatrick, D. R. (2011) Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg Anophthalmia) syndrome in humans and mice. PLoS Genet. 7, e1002114.
DOI
|
72 |
James, R. G., Bosch, K. A., Kulikauskas, R. M., Yang, P. T., Robin, N. C., Toroni, R. A., Biechele, T. L., Berndt, J. D., von Haller, P. D., Eng, J. K., Wolf-Yadlin, A., Chien, A. J. and Moon, R. T. (2013) Protein Kinase PKN1 represses Wnt/beta-catenin signaling in human melanoma cells. J. Biol. Chem. 288, 34658-34670.
DOI
ScienceOn
|
73 |
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D. and Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
DOI
ScienceOn
|
74 |
Xiao, Z., Camalier, C. E., Nagashima, K., Chan, K. C., Lucas, D. A., de la Cruz, M. J., Gignac, M., Lockett, S., Issaq, H. J., Veenstra, T. D., Conrads, T. P. and Beck, G. R., Jr. (2007) Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J. Cell Physiol. 210, 325-335.
DOI
ScienceOn
|